Rajnish Wellness

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE685Z01033
  • NSEID:
  • BSEID: 541601
INR
0.68
0.00 (0.00%)
BSENSE

Dec 04

BSE+NSE Vol: 6943839

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

69.44 lacs (-29.62%) Volume

Shareholding (Sep 2025)

FII

0.43%

Held by 1 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

9.16%

What does Rajnish Wellness do?

06-Jun-2025

Rajnish Wellness Ltd is a micro-cap company in the Pharmaceuticals & Biotechnology industry, selling consumer durables and ayurvedic personal care products. It was incorporated in 2015, became a public company in 2018, and reported net sales of 6 Cr and no profit for the quarter ending March 2025.

Overview: <BR>Rajnish Wellness Ltd is engaged in selling a variety of products, including consumer durables and ayurvedic personal care products, and operates within the Pharmaceuticals & Biotechnology industry in the micro-cap market.<BR><BR>History: <BR>Rajnish Wellness Ltd was originally incorporated on June 13, 2015, as a Private Limited Company under the name "Rajnish Hot Deals Private Limited." It was converted into a Public Limited Company on February 01, 2018, and subsequently renamed to "Rajnish Wellness Limited" on February 09, 2018. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 6 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 115 Cr (Micro Cap) <BR><BR>Key Metrics: <BR>P/E: 115.00 <BR>Industry P/E: 54 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.00 <BR>Return on Equity: 0.07% <BR>Price to Book: 1.37 <BR><BR>Contact Details: <BR>Address: Bldg No 3 Navijivan Comm Socie, 6 Th Floor Office No 10L Mumbai Maharashtra : 400008 <BR>Tel: 91-22-23065555 <BR>Email: info@rajnishwellness.com <BR>Website: http://www.rajnishwellness.com

Read More

What is the bonus history of the Rajnish Wellness?

06-Jun-2025

Rajnish Wellness has a recent bonus history that includes a 2:1 bonus announced on July 21, 2022, and a 5:4 bonus issued on December 23, 2021, reflecting the company's commitment to rewarding shareholders.

Rajnish Wellness has a notable bonus history. The most recent bonus issue was a 2:1 bonus, which was announced with an ex-date of July 21, 2022, and a record date of July 22, 2022. Prior to that, the company issued a 5:4 bonus with an ex-date of December 23, 2021, and a record date of December 24, 2021. This indicates that Rajnish Wellness has been active in rewarding its shareholders through bonus issues in the recent past.

Read More

Has Rajnish Wellness declared dividend?

06-Jun-2025

No Dividend History Available

What is the technical trend for Rajnish Wellness?

09-Jun-2025

As of June 6, 2025, Rajnish Wellness shows a bearish trend with weak strength, supported by bearish monthly indicators and daily moving averages, despite some mixed signals from the MACD and RSI.

As of 6 June 2025, the technical trend for Rajnish Wellness has changed from mildly bearish to bearish. The current stance is bearish with weak strength. The weekly MACD is mildly bullish, but the monthly MACD and KST are bearish, indicating a lack of strong upward momentum. The RSI shows no signal on the weekly chart while being bullish on the monthly, suggesting mixed signals. Both the weekly and monthly Bollinger Bands are bearish, reinforcing the downward trend. Daily moving averages are bearish, further supporting the negative outlook. Overall, the indicators suggest a prevailing bearish sentiment in the short to medium term.

Read More

Who are the peers of the Rajnish Wellness?

16-Jul-2025

Peers of Rajnish Wellness include Denis Chem Lab, Amwill Health, Parnax Lab, and others. Rajnish Wellness has below-average management risk and capital structure, with a 1-year return of -79.46%, the lowest among its peers.

Peers: The peers of Rajnish Wellness are Denis Chem Lab, Amwill Health, Parnax Lab, Samrat Pharma, Mercury Labs, Bharat Immunolog, Source Natural, Zenith Drugs, Vaishali Pharma, and Ajooni Biotech.<BR><BR>Quality Snapshot: Excellent management risk is observed at Amwill Health and Source Natural, while Good management risk is found at Samrat Pharma and Zenith Drugs. Average management risk is present at Denis Chem Lab, Rajnish Wellness, and Mercury Labs, while Below Average management risk is noted at Parnax Lab, Bharat Immunolog, Vaishali Pharma, and Ajooni Biotech. Growth is Excellent at Rajnish Wellness, Good at Amwill Health and Parnax Lab, while Below Average growth is seen at Denis Chem Lab, Mercury Labs, Bharat Immunolog, Source Natural, Zenith Drugs, and Vaishali Pharma, with the rest having Below Average growth. Capital Structure is Excellent at Amwill Health, Parnax Lab, Samrat Pharma, and Mercury Labs, while Rajnish Wellness has Below Average capital structure, and the rest have Below Average or Average capital structures.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Parnax Lab at 9.25%, while the peer with the lowest is Rajnish Wellness at -79.46%. Rajnish Wellness's 1-year return is significantly lower than all peers. Additionally, the following peers have negative six-month returns: Denis Chem Lab, Rajnish Wellness, Mercury Labs, Bharat Immunolog, Source Natural, and Vaishali Pharma.

Read More

Who are in the management team of Rajnish Wellness?

16-Jul-2025

As of March 2020, the management team of Rajnish Wellness includes Rajnishkumar Surendra Prasad Singh (Managing Director), Shalini Vijendra Mishra (Whole-time Director and Non-Executive Director), several independent directors, and company secretaries, totaling 11 members. This diverse team oversees the company's governance and management.

As of March 2020, the management team of Rajnish Wellness includes the following members:<BR><BR>1. Rajnishkumar Surendra Prasad Singh - Managing Director<BR>2. Shalini Vijendra Mishra - Whole-time Director<BR>3. Shalini Vijendra Mishra - Non Executive Director<BR>4. Abhinandan Ashok Kumar Paliwal - Independent Director<BR>5. Madhukar Devappa Imade - Independent Director<BR>6. Heet Ashok Shah - Company Secretary<BR>7. Sanjjari Kashyap - Additional Director<BR>8. Rajveer Singh - Company Secretary<BR>9. Monam Kapoor - Independent Director<BR>10. Swati Jain - Additional Director<BR>11. Saloni Mehra - Additional Director<BR><BR>This team comprises a mix of directors and company secretaries, contributing to the governance and management of the company.

Read More

Who are the top shareholders of the Rajnish Wellness?

17-Jul-2025

The top shareholders of Rajnish Wellness include promoter Rajnish Kumar Singh with 7.41%, individual investors holding 82.53%, and Skybridge Incap Advisory LLP as the largest public shareholder at 1.37%. The majority of shares are held by non-institutional investors, with no mutual fund holdings.

The top shareholders of Rajnish Wellness include Rajnish Kumar Singh, who is the promoter with the highest holding at 7.41%. The company also has a significant portion of individual investors holding 82.53% of the shares. Additionally, Skybridge Incap Advisory LLP is the highest public shareholder, holding 1.37%. There is one foreign institutional investor (FII) that holds 0.57% of the shares, while mutual funds do not hold any shares in the company. Overall, the majority of the shareholding is with non-institutional investors.

Read More

How big is Rajnish Wellness?

24-Jul-2025

As of 24th July, Rajnish Wellness Ltd has a market capitalization of 118.00 Cr, with recent net sales of 48.55 Cr and a net profit of 0.06 Cr. The balance sheet for March 2024 shows shareholder's funds of 83.99 Cr and total assets of 106.26 Cr.

As of 24th July, Rajnish Wellness Ltd has a market capitalization of 118.00 Cr, categorized as a Micro Cap.<BR><BR>In the latest four quarters, the company reported Net Sales of 48.55 Cr and a Net Profit of 0.06 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 83.99 Cr and Total Assets of 106.26 Cr.

Read More

Are Rajnish Wellness latest results good or bad?

15-Aug-2025

The latest results for Rajnish Wellness are largely negative, with a significant 76.13% year-on-year decline in net sales, despite a notable 147.83% increase in net profit. The company faces serious concerns about its financial health, reflected in a 'Strong Sell' rating.

The latest results for Rajnish Wellness indicate a challenging situation for the company. For the quarter ending June 2025, net sales experienced a significant decline of 76.13% year-on-year, which raises concerns about the company's sales performance. While there was a slight improvement in the financial score from -14 to -6 over the past three months, the overall outlook remains negative, particularly in terms of sales growth.<BR><BR>On a quarterly basis, there was a decrease in net sales of 20.97% compared to the previous quarter, although the standalone net profit showed a remarkable increase of 147.83%. Despite this positive shift in profit, the substantial drop in sales and the 'Strong Sell' rating from MarketsMOJO reflect serious concerns about the company's financial health.<BR><BR>In summary, while there are some signs of improvement in profit margins, the overall results are largely viewed as negative due to the drastic decline in sales. The company will need to address these issues to improve its standing in the competitive pharmaceuticals and biotechnology sector.

Read More

When is the next results date for Rajnish Wellness?

11-Nov-2025

The next results date for Rajnish Wellness is 14 November 2025.

The next results date for Rajnish Wellness is scheduled for 14 November 2025.

Read More

How has been the historical performance of Rajnish Wellness?

17-Nov-2025

Rajnish Wellness has experienced significant financial fluctuations, with net sales dropping from INR 76.68 crore in March 2024 to INR 48.56 crore in March 2025, alongside declines in profits and negative cash flow. Overall, the company is facing a challenging period marked by decreasing revenues and profits.

Answer:<BR>The historical performance of Rajnish Wellness shows significant fluctuations in its financial metrics over the years.<BR><BR>Breakdown:<BR>Rajnish Wellness experienced a decline in net sales from INR 76.68 crore in March 2024 to INR 48.56 crore in March 2025, following a notable increase from INR 25.03 crore in March 2023. The total operating income mirrored this trend, dropping to INR 48.56 crore in March 2025 from INR 76.68 crore in the previous year. The company reported no raw material costs, and the purchase of finished goods decreased to INR 46.33 crore in March 2025 from INR 76.54 crore in March 2024. Operating profit (PBDIT) fell to INR 0.52 crore in March 2025, down from INR 1.97 crore in March 2024, while profit before tax also decreased to INR 0.23 crore from INR 1.45 crore. Consequently, profit after tax dropped to INR 0.17 crore in March 2025 from INR 1.03 crore in the previous year. The company's total assets decreased to INR 91.28 crore in March 2025 from INR 106.26 crore in March 2024, and total liabilities also fell to INR 91.28 crore from INR 106.26 crore. Cash flow from operating activities was negative at INR -4.00 crore in March 2025, contrasting with a positive cash flow of INR 1.00 crore in March 2024. Overall, the financial performance of Rajnish Wellness reflects a challenging period with declining revenues and profits.

Read More

Is Rajnish Wellness overvalued or undervalued?

18-Nov-2025

As of November 17, 2025, Rajnish Wellness is considered overvalued and risky, with a PE ratio of -738.43 and a year-to-date return of -44.06%, significantly underperforming compared to peers like Hindustan Unilever and Nestle India.

As of 17 November 2025, the valuation grade for Rajnish Wellness has moved from expensive to risky, indicating a significant deterioration in its perceived value. The company is currently assessed as overvalued. Key ratios highlight this concern, with a PE ratio of -738.43, an EV to EBITDA of -81.01, and a ROE of -0.13%. <BR><BR>When compared to peers, Rajnish Wellness stands out negatively against companies such as Hindustan Unilever, which has a PE ratio of 53.89, and Nestle India with a PE of 81.88. The stark contrast in valuation metrics underscores the challenges Rajnish Wellness faces in the market. Additionally, the company's stock has underperformed significantly, with a year-to-date return of -44.06% compared to the Sensex's positive return of 8.72%, reinforcing the notion of overvaluation in the current context.

Read More

Should I buy, sell or hold Rajnish Wellness?

19-Nov-2025

Why is Rajnish Wellness falling/rising?

05-Dec-2025

As of 04-Dec, Rajnish Wellness Ltd's stock price is at 0.68, unchanged from the previous day, but has seen significant declines over various periods, including a 61.36% drop over the past year. Despite a recent increase in investor participation, the stock remains below key moving averages, indicating a bearish trend.

As of 04-Dec, Rajnish Wellness Ltd's stock price is currently at 0.68, showing no change from the previous day. However, the stock has been experiencing a significant decline over various periods. Over the past week, the stock has fallen by 11.69%, and in the last month, it has decreased by 13.92%. Year-to-date, the stock is down 52.45%, and over the past year, it has dropped 61.36%. The three-year performance shows a drastic decline of 95.15%, although there has been a substantial increase of 376.99% over the past five years.<BR><BR>Today, the stock hit a new 52-week low of Rs. 0.65, indicating a downward trend. Additionally, it has underperformed its sector by 0.45%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which typically suggests a bearish sentiment among investors. <BR><BR>Despite these negative indicators, there has been a rise in investor participation, with a delivery volume of 79.53 lacs on December 3, which is up by 39.21% compared to the 5-day average. This suggests some interest in the stock, but overall, the prevailing trends indicate that Rajnish Wellness Ltd is currently experiencing a decline in its stock price.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of 9.56% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.71
2

Flat results in Sep 25

3

Risky - Negative EBITDA

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 69 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

54

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

-0.10%

stock-summary
Price to Book

0.63

Revenue and Profits:
Net Sales:
12 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-33.98%
0%
-33.98%
6 Months
-27.66%
0%
-27.66%
1 Year
-61.36%
0%
-61.36%
2 Years
-93.8%
0%
-93.8%
3 Years
-95.15%
0%
-95.15%
4 Years
-52.78%
0%
-52.78%
5 Years
376.99%
0%
376.99%

Rajnish Wellness for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
Announcements stock-summary

Revised Unaudited Financial Results For Quarter And Half Year Ended 30Th September 2025

29-Nov-2025 | Source : BSE

Revised Unaudited Financial Results for quarter and half year ended 30th September 2025

Announcement under Regulation 30 (LODR)-Newspaper Publication

15-Nov-2025 | Source : BSE

Submission of Newspaper Clippings of Un-audited Financial Results for quarter and half year ended September 30 2025.

Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Friday November 14 2025

14-Nov-2025 | Source : BSE

Outcome of Board Meeting held today i.e. Friday November 2025

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

Rajnish Wellness Ltd has announced 1:2 stock split, ex-date: 10 Jan 23

stock-summary
BONUS

Rajnish Wellness Ltd has announced 2:1 bonus issue, ex-date: 21 Jul 22

stock-summary
RIGHTS

Rajnish Wellness Ltd has announced 19:30 rights issue, ex-date: 03 Jun 25

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
9.56%
EBIT Growth (5y)
20.40%
EBIT to Interest (avg)
-0.71
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.01
Sales to Capital Employed (avg)
0.62
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.43%
ROCE (avg)
-2.26%
ROE (avg)
0.25%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
54
Price to Book Value
0.63
EV to EBIT
-67.91
EV to EBITDA
-67.91
EV to Capital Employed
0.63
EV to Sales
2.16
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.51%
ROE (Latest)
-0.10%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.43%)

Promoter with highest holding

Rajnish Kumar Singh (9.16%)

Highest Public shareholder

Dealmoney Commodities Private Limited (4.24%)

Individual Investors Holdings

79.89%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 163.16% vs -20.97% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -72.73% vs 147.83% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.00",
          "val2": "4.56",
          "chgp": "163.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.23",
          "val2": "0.18",
          "chgp": "-227.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.06",
          "val2": "0.22",
          "chgp": "-72.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1.92%",
          "val2": "3.95%",
          "chgp": "-5.87%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -50.89% vs 24.80% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -36.36% vs -32.31% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16.56",
          "val2": "33.72",
          "chgp": "-50.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.04",
          "val2": "0.48",
          "chgp": "-108.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.23",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.28",
          "val2": "0.44",
          "chgp": "-36.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-0.24%",
          "val2": "1.42%",
          "chgp": "-1.66%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -12.05% vs 153.47% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -32.00% vs -47.92% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "42.78",
          "val2": "48.64",
          "chgp": "-12.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.61",
          "val2": "0.37",
          "chgp": "64.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.27",
          "val2": "0.39",
          "chgp": "-30.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.51",
          "val2": "0.75",
          "chgp": "-32.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.43%",
          "val2": "0.76%",
          "chgp": "0.67%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -36.67% vs 206.35% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -83.50% vs 123.91% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "48.56",
          "val2": "76.68",
          "chgp": "-36.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "1.97",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.27",
          "val2": "0.51",
          "chgp": "-47.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.17",
          "val2": "1.03",
          "chgp": "-83.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "2.57%",
          "chgp": "-2.57%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQstock-summary
Sep'25
Jun'25
Change(%)
Net Sales
12.00
4.56
163.16%
Operating Profit (PBDIT) excl Other Income
-0.23
0.18
-227.78%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.06
0.22
-72.73%
Operating Profit Margin (Excl OI)
-1.92%
3.95%
-5.87%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 163.16% vs -20.97% in Jun 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is -72.73% vs 147.83% in Jun 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
16.56
33.72
-50.89%
Operating Profit (PBDIT) excl Other Income
-0.04
0.48
-108.33%
Interest
0.00
0.23
-100.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.28
0.44
-36.36%
Operating Profit Margin (Excl OI)
-0.24%
1.42%
-1.66%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -50.89% vs 24.80% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -36.36% vs -32.31% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
42.78
48.64
-12.05%
Operating Profit (PBDIT) excl Other Income
0.61
0.37
64.86%
Interest
0.27
0.39
-30.77%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.51
0.75
-32.00%
Operating Profit Margin (Excl OI)
1.43%
0.76%
0.67%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -12.05% vs 153.47% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -32.00% vs -47.92% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
48.56
76.68
-36.67%
Operating Profit (PBDIT) excl Other Income
0.00
1.97
-100.00%
Interest
0.27
0.51
-47.06%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.17
1.03
-83.50%
Operating Profit Margin (Excl OI)
0.00%
2.57%
-2.57%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -36.67% vs 206.35% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -83.50% vs 123.91% in Mar 2024

stock-summaryCompany CV
About Rajnish Wellness Ltd stock-summary
stock-summary
Rajnish Wellness Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Rajnish Wellness Limited was originally incorporated on June 13, 2015 as a Private Limited Company under the name and style of "Rajnish Hot Deals Private Limited". Subsequently, the Company was converted into a Public Limited Company on February 01, 2018 and was renamed to "Rajnish Wellness Limited" on February 09, 2018. The Company is currently engaged in the business of selling various products in the categories ranging from consumer durables to ayurvedic personal care products.
Company Coordinates stock-summary
Company Details
Bldg No 3 Navijivan Comm Socie, 6 Th Floor Office No 10L Mumbai Maharashtra : 400008
stock-summary
Tel: 91-22-23065555
stock-summary
info@rajnishwellness.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai